| ||||||||||||
Entries tagged "Bristol-Myers Squibb"Bristol-Myers looking to swallow Elan in piecesRumors of Bristol-Myers Squibb interest in the auction of Irish biotech Elan sent shares up in London trading. Is Bristol-Myers the next pharma target?So three megamergers in healthcare, and Bristol-Myers Squibb, which has been rumored to be a takeover target since last summer, is still standing alone. Here comes pharma's 'me-too' mergersThe pharmaceutical industry is notorious for creating copycat drugs. Now Pfizer's $68 billion bid for Wyeth could prompt Merck, Sanofi-Aventis and other peers to launch 'me-too' mergers. Bristol-Myers could make ImClone a hard pill to swallowSo Carl Icahn wasn't bluffing. Eli Lilly and Co. is apparently the mystery bidder for ImClone Systems Inc., and the company is in talks to acquire the New York-based biotech company for $6.1 billion, according to a report by The Wall Street Journal. ... Rabble Babble: ImClone's mystery bidder to reveal itself this weekImClone Systems Inc. said a mystery bidder, which has tentatively offered a bid of $70 a share or $6.1 billion, has informed the company that it will either make a formal bid or withdraw from talks by the end of the day on Wednesday. ... Will someone swallow Bristol-Myers?Could Bristol-Myers Squibb Co. be entertaining a sale in the future? Sanford C. Bernstein & Co. LLC analyst Tim Anderson might answer "good chance" based on a note he recently wrote, according to a Reuters article. ... Top tagsYou have executed a tag search on Dealscape. On the left,you will find a comprehensive list of stories tagged "Bristol-Myers Squibb." Below are the most-popular tags for Dealscape. On the right of the page you will find a search box to dig deeper into our content.
![]()
![]() ![]() ![]() ![]() Community
![]() Elsewhere on The Deal.comDealwatch
The Deal MagazineCorporate Dealmaker
The Deal VideoCategories
Blog roll
Archives
| ||||||||||||
| ||||||||||||